HIV envelope DNA/protein vaccine (Harvard)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHIV envelope DNA/protein vaccine (Harvard)

Drug Alias NameHIV vaccine (Harvard Medical School)

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHarvard Medical School

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHarvard Medical School

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A